Related references
Note: Only part of the references are listed.Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance
Ala M. Shaqra et al.
NATURE COMMUNICATIONS (2022)
Comprehensive fitness landscape of SARS-CoV-2 M-pro reveals insights into viral resistance mechanisms
Julia M. Flynn et al.
ELIFE (2022)
A white-knuckle ride of open COVID drug discovery
Frank von Delft et al.
NATURE (2021)
An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 Mpro inhibitor
Daniel Zaidman et al.
CELL CHEMICAL BIOLOGY (2021)
Chemoproteomics-enabled discovery of covalent RNF114-based degraders that mimic natural product function
Mai Luo et al.
CELL CHEMICAL BIOLOGY (2021)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Covalent inhibitors: a rational approach to drug discovery
Fandi Sutanto et al.
RSC MEDICINAL CHEMISTRY (2020)
Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications
Carl C. Ward et al.
ACS CHEMICAL BIOLOGY (2019)
Development of Novel Peptidomimetics Containing a Vinyl Sulfone Moiety as Proteasome Inhibitors
Roberta Ettari et al.
CHEMMEDCHEM (2011)